Literature DB >> 33578830

Interplay between the Gut Microbiota and Inflammatory Mediators in the Development of Colorectal Cancer.

Gwangbeom Heo1, Yunna Lee1, Eunok Im1.   

Abstract

Inflammatory mediators modulate inflammatory pathways during the development of colorectal cancer. Inflammatory mediators secreted by both immune and tumor cells can influence carcinogenesis, progression, and tumor metastasis. The gut microbiota, which colonize the entire intestinal tract, especially the colon, are closely linked to colorectal cancer through an association with inflammatory mediators such as tumor necrosis factor, nuclear factor kappa B, interleukins, and interferons. This association may be a potential therapeutic target, since therapeutic interventions targeting the gut microbiota have been actively investigated in both the laboratory and in clinics and include fecal microbiota transplantation and probiotics.

Entities:  

Keywords:  colorectal cancer; fecal microbiota transplantation; germ-free animal; inflammatory mediators; microbiota

Year:  2021        PMID: 33578830      PMCID: PMC7916585          DOI: 10.3390/cancers13040734

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  134 in total

1.  Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Authors:  Kanstantsin V Katlinski; Jun Gui; Yuliya V Katlinskaya; Angelíca Ortiz; Riddhita Chakraborty; Sabyasachi Bhattacharya; Christopher J Carbone; Daniel P Beiting; Melanie A Girondo; Amy R Peck; Ellen Puré; Priya Chatterji; Anil K Rustgi; J Alan Diehl; Constantinos Koumenis; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

2.  Role of inflammation and inflammatory mediators in colorectal cancer.

Authors:  Raymond N Dubois
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

3.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

5.  Probiotic strains modulate cytokine production and the immune interplay between human peripheral blood mononucear cells and colon cancer cells.

Authors:  Meir Djaldetti; Hanna Bessler
Journal:  FEMS Microbiol Lett       Date:  2017-02-01       Impact factor: 2.742

Review 6.  The paradoxical role of IL-10 in immunity and cancer.

Authors:  Mark H Mannino; Ziwen Zhu; Huaping Xiao; Qian Bai; Mark R Wakefield; Yujiang Fang
Journal:  Cancer Lett       Date:  2015-07-15       Impact factor: 8.679

Review 7.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

8.  The Interferon-Gamma Paradox in Cancer.

Authors:  M Raza Zaidi
Journal:  J Interferon Cytokine Res       Date:  2018-11-09       Impact factor: 2.607

Review 9.  TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors.

Authors:  Yuqiao Sheng; Feng Li; Zhihai Qin
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

Review 10.  Role of STAT3 signaling pathway in breast cancer.

Authors:  Jia-Hui Ma; Li Qin; Xia Li
Journal:  Cell Commun Signal       Date:  2020-02-28       Impact factor: 5.712

View more
  2 in total

Review 1.  Effect of gut microbiota in the colorectal cancer and potential target therapy.

Authors:  Junchuan Li; Yuzhou Zhu; Lie Yang; Ziqiang Wang
Journal:  Discov Oncol       Date:  2022-06-24

Review 2.  Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.

Authors:  Bartosz Kamil Sobocki; Karolina Kaźmierczak-Siedlecka; Marcin Folwarski; Viktoria Hawryłkowicz; Wojciech Makarewicz; Ewa Stachowska
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.